Wednesday, 26 August 2026European Markets

AVENIR TELECOM Stock Impressive Rise On Monday, Outperforms Market

Loading stream...

(vianews) - the market ended the session with avenir telecom (avt.pa) rising 16.12% to €0.19 on monday while cac 40 slid 0.04% to €7,573.86.

about avenir telecom

avenir telecom s.a. designs and distributes mobile phones and mobility accessories in europe, the middle east, africa, asia, oceania, and the americas. the company also provides chargers, cables, memory cards, and screen protectors. it offers its products under the energizer brand. the company was incorporated in 1989 and is headquartered in marseille, france.

earnings per share

as for profitability, avenir telecom has a trailing twelve months eps of €102.06.

volatility

avenir telecom's last week, last month's, and last quarter's current intraday variation average was a negative 16.67%, a negative 4.82%, and a positive 9.16%.

avenir telecom's highest amplitude of average volatility was 16.67% (last week), 6.41% (last month), and 9.16% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, avenir telecom's stock is considered to be overbought (>=80).

volume

today's last reported volume for avenir telecom is 2787700 which is 39.89% below its average volume of 4637980.

more news about avenir telecom (avt.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com